Order Article Reprints

Burger JPW, van Lochem EG, Roovers EA, Drenth JPH, Wahab PJ. Dose-Escalating (50–500 mg) Gluten Administration Leads to Detectable Gluten-Immunogenic-Peptides in Urine of Patients with Coeliac Disease Which Is Unrelated to Symptoms, a Placebo Controlled Trial. Nutrients. 2022; 14(9):1771. https://doi.org/10.3390/nu14091771

Burger, Jordy P. W., Ellen G. van Lochem, Elisabeth A. Roovers, Joost P. H. Drenth, and Peter J. Wahab. 2022. "Dose-Escalating (50–500 mg) Gluten Administration Leads to Detectable Gluten-Immunogenic-Peptides in Urine of Patients with Coeliac Disease Which Is Unrelated to Symptoms, a Placebo Controlled Trial" Nutrients 14, no. 9: 1771. https://doi.org/10.3390/nu14091771

Burger, J. P. W., van Lochem, E. G., Roovers, E. A., Drenth, J. P. H., & Wahab, P. J. (2022). Dose-Escalating (50–500 mg) Gluten Administration Leads to Detectable Gluten-Immunogenic-Peptides in Urine of Patients with Coeliac Disease Which Is Unrelated to Symptoms, a Placebo Controlled Trial. Nutrients, 14(9), 1771. https://doi.org/10.3390/nu14091771